Medical Devices

European medicines and medical devices: Future trends
2023-03-07T13:28:00+00:00
Understanding key components
of a clinical evaluation
2023-03-03T12:29:00+00:00By Angela Siebeneck
Regulation versus innovation in life sciences
2023-02-07T09:27:00+00:00By Richard Bassett
IVDs and medical devices — post-market surveillance and clinical follow-up requirements
2023-02-07T09:27:00+00:00By Kirsten Van Garsse
Successful transition of your ISO 13485 QMS from MDD/IVDD to MDR/IVDR
2023-02-07T09:25:00+00:00By Niamh Miller, Laura Taylor
Medical Device Standards Update
2022-10-31T14:41:00+00:00By Mehryar Behizad
Navigating the MDR’s heightened surveillance and performance requirements
2022-09-16T09:25:00+01:00By Ana Quinn
EU expert panels for high-risk devices - another level of review?
2022-09-16T09:25:00+01:00By Colleen Watson, Frances J Richmond
The importance of subjective and qualitative risk management for medical devices regulation
2022-09-16T09:25:00+01:00By Neil Armstrong
The new UK MDR - a great start to a long road ahead
2022-09-16T09:25:00+01:00By Richard Bassett
One year experience on EU Medical Devices Regulation (MDR) 2017/745 for single integral drug-device combination products
2022-06-23T10:39:00+01:00By Giovanni Campana
Translating digitalisation trends into tangible solutions
2022-06-22T15:51:00+01:00By Timm Pauli, Torsten Osthus
What can past decision-making data tell us about how the FDA will make future combination product categorisation decisions?
2022-05-26T11:04:00+01:00By Farha Sayeed
Medical device standards update
2022-05-25T10:27:00+01:00By Mehryar Behizad
Practical insights into the recent EU MDR framework
2022-04-18T13:18:00+01:00By Akhilesh Sharma, Dharti Shah, Pinki Mishra, Rakesh Suman, Shikha Tyagi, Nehal Bagga, Harika Potta, Karen Taylor-Worth, Suzie Ribeiro, Vesna Sevaljevic, Alyssa Schmidt, Stephanie Snow, Steve LoCastro, Vivek Tomar, Stuart Goodall
The national competent authorities of Belgium and Luxembourg share their views about the e-PIL Pilot
2022-03-24T11:24:00+00:00By Nathalie Lambot, Marie Vande Ginste
Planning for the future: sustainable medical devices
2022-03-24T10:50:00+00:00By Alastair Willoughby
Electronic leaflet pilot in Belgium and Luxembourg hospitals
2022-03-23T11:07:00+00:00By Nathalie Lambot, Marie Vande Ginste
A review of Project Orbis: An initiative enabling faster patient access to cancer therapies
2022-02-23T14:16:00+00:00By Leah Kleylein
New regulatory tools for drug developers: sharing experience
2022-01-24T14:21:00+00:00By Patrick Larcier, Dr. Christian K Schneider, Frederic Pailloux
Substance-based medical devices: regulatory challenges and prospects
2021-12-23T13:59:00+00:00By Oliver Hartmann